QIAGEN N.V. announced the launch of its next-generation automated nucleic acid purification platform, QIAsymphony Connect, at the AMP 2025 Annual Meeting in Boston, designed...
xM MRD and NeXT Personal Dx tests are now available for physicians in the U.S. for early cancer recurrence detection and residual disease monitoring
Tempus,...